Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01509950
Other study ID # 22389
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2012
Est. completion date May 4, 2013

Study information

Verified date November 2018
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Currently different materials are used to close the skin after a cesarean delivery, including absorbable suture, non-absorbable suture and staples. It is not known what is the best choice of material to close the skin after a cesarean section, but commonly staples or dissolvable suture is used. Recently plastic surgeons have found that non-dissolvable suture may have a better cosmetic outcome than staples. The investigators hope to learn if there is a difference in pain both at suture/staple removal and 6 weeks postoperatively between Prolene suture, Absorbable suture (monocryl or vicryl) or staples. The investigators also plan to look for differences in wound complications and patient satisfaction, as well as operating and removal times. This knowledge will be important in helping practitioners choose the closure technique at cesarean delivery.


Description:

Patients who meet inclusion criteria will be approached upon admission to Labor and Delivery. A study staff member will describe the study and offer participation. If a patient agrees to participate, she will sign research protocol and HIPAA consent forms and receive a copy of these forms. The patient's chart will be flagged, indicating that she is a study participant. The patient's prenatal care and labor and delivery will be managed by her physician per standard of care at the physician's discretion, including routine surgical preparation and procedures.

When a participating patient is scheduled for a cesarean section, she will be randomized to Arm 1 (Staples) or Arm 2 (Prolene) or Arm 3 (Monocryl or Vicryl absorbable suture). She will be treated as per standard of care and her cesarean section performed per physician discretion. After the closure of the fascial layer, the surgeons will follow the same protocol for each study participant, including wound irrigation with warm sterile saline and reapproximation of the subcutaneous layer if greater than 2.0 cm in depth (per standard of care). The patient in Arm 1 will have skin closure with staples. The patient in Arm 2 will have skin closure with 2-0 Prolene in a subcuticular fashion. The patient in Arm 3 will have skin closure with monocryl or vicryl in the standard fashion. Patients in Arms 1 and 2 will have their closure material removed at the physician's discretion per the standard of care at post-operative day 3 or 4.

Pain level will be assessed on the first and third or fourth day after surgery and again at six weeks.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date May 4, 2013
Est. primary completion date May 4, 2013
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- Pregnant women undergoing primary or repeat cesarean section

- Maternal age greater than or equal to 18 years of age

- Gestational age greater than or equal to 34 weeks

- Elective and non-elective cesarean section

Exclusion Criteria:

- Type 1 or Type 2 diabetes

- BMI greater than 35

- Pre-operative diagnosis of chorioamnionitis

- History of drug or alcohol abuse

- Contraindication to NSAIDs

- Chronic pain diagnosis

- Narcotic use prior to pregnancy

- Maternal age less than 18 years of age

- General anesthesia

- Chorioamnionitis, clinical suspicion of chorioamnionitis, or risk factors for chorioamnionitis (membrane rupture greater than 18 hours, GBS positive status)

- Vertical skin incision

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Staples
Staples for closure of cesarean section skin incision
Prolene non-absorbable sutures
Prolene non-absorbable sutures for closure of cesarean skin incision
Absorbable Sutures
Absorbable sutures for closure of cesarean skin incision

Locations

Country Name City State
United States Lucile Packard Childrens Hospital Palo Alto California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Level of Pain on a Scale During the Post-operative Hospitalization Period Pain level on a Mosby visual analog pain scale of 1 (no pain) to 10 (worst pain) Post-operative day 3 or 4.
Secondary Level of Pain on a Scale at 6 Weeks Postpartum Pain level on a scale (Mosby visual analog pain scale) of 1 (no pain) to 10 (worst pain). Post-operative week 6
Secondary Count of Participants With Wound Complications Wound complications include conditions like infection, seroma/hematoma and dehiscence Post-operative week 6
Secondary Level of Patient Satisfaction to the Wound Appearance Level of patient satisfaction measured on a scale of 1 (very unsatisfied) to 10 (very satisfied) Post-operative day 3 or 4
Secondary Level of Patient Satisfaction to the Wound Appearance at 6 Weeks Postpartum Level of patient satisfaction measured on a scale of 1 (very unsatisfied) to 10 (very satisfied) Post-operative week 6
Secondary Time From Skin Incision to the Skin Closure Measured in minutes Day of cesarean delivery (up to 8 hours)
Secondary Time Needed for the Suture Removal Measured in seconds Post-operative day 3 or 4
Secondary Level of Patient's Satisfaction to the Cosmesis of the Wound Measured on a scale of 0 (very unsatisfied to the cosmesis) to 10 (very satisfied to the cosmesis) Post-operative week 6
Secondary Level of Patient's Overall Patient Satisfaction to the Type of Closure Level of patient satisfaction measured on a scale of 1 (very unsatisfied) to 10 (very satisfied) Post-operative day 1
Secondary Level of Patient's Overall Patient Satisfaction to the Type of Closure Level of patient satisfaction measured on a scale of 1 (very unsatisfied) to 10 (very satisfied) Post-operative day 3 or 4
Secondary Level of Patient's Overall Patient Satisfaction to the Type of Closure Level of patient satisfaction measured on a scale of 1 (very unsatisfied) to 10 (very satisfied) Post-operative week 6
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) Phase 3